MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3109/07853890.2014.941919

Медицинская библиотека · Annals of medicine · 2014

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.

Lorenzetti Roberto, Zullo Angelo, Ridola Lorenzo, Diamanti Andrea Picchianti, Laganà Bruno, Gatta Luigi, Migliore Alberto, Armuzzi Alessandro, Hassan Cesare, Bruzzese Vincenzo

СтатьяСистематический обзорПеревод в очереди

Аннотация

OBJECTIVE

Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

METHODS

We searched for randomized controlled trials (RCTs) evaluating infliximab, adalimumab, and certolizumab in both rheumatologic and non-rheumatologic diseases until 2012. Results were calculated as pooled rates and/or pooled odd ratios (OR).

RESULTS

Overall, 40 RCTs with a total of 14,683 patients (anti-TNF: 10,010; placebo: 4673) were included. TB reactivation was 0.26% (26/10,010) in the anti-TNF group and 0% (0/4673) in the control group, corresponding to an OR of 24.8 (95% CI 2.4-133). TB risk was higher when anti-TNF agents were combined with methotrexate or azathioprine as compared with either controls (24/4241 versus 0/4673; OR 54; 95% CI 5.3-88) or anti-TNF monotherapy (24/4241 versus 2/5769; OR 13.3; 95% CI 3.7-100). When anti-TNF was used as monotherapy, TB risk tended to be higher than placebo (2/5769 versus 0/4673; OR 4; 95% CI 0.2-15.7).

CONCLUSIONS

TB risk with anti-TNF agents appeared to be increased when these agents were used in combination with methotrexate or azathioprine as compared with monotherapy regimen. TB risk seemed to be higher than placebo, even when monotherapy is prescribed.

Для цитирования: Lorenzetti Roberto, Zullo Angelo, Ridola Lorenzo, Diamanti Andrea Picchianti, Laganà Bruno, Gatta Luigi, Migliore Alberto, Armuzzi Alessandro, Hassan Cesare, Bruzzese Vincenzo. Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.. Annals of medicine. 2014. DOI: 10.3109/07853890.2014.941919.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.